Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 7—July 2022
Research Letter

Mental Health Conditions and Severe COVID-19 Outcomes after Hospitalization, United States

Alain K. KoyamaComments to Author , Emilia H. Koumans, Kanta Sircar, Amy M. Lavery, Jean Y. Ko, Joy Hsu, Kayla N. Anderson, and David A. Siegel
Author affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Table

Characteristics of 664,956 hospitalized COVID-19 patients, by mental health condition diagnosis, from the Premier Healthcare Database Special COVID-19 Release, United States, March 2020–July 2021*

Parameter No. (%) patients
No mental health conditions Anxiety Depression Bipolar disorder Schizophrenia
Total
485,784 (73.1)
114,902 (17.3)
96,167 (14.5)
15,370 (2.3)
12,304 (1.9)
Patient characteristics
Age group, y
0–17 5,415 (1.1) 608 (0.5) 584 (0.6) 97 (0.6) 25 (0.2)
18–39 61,751 (12.7) 11,584 (10.1) 7,598 (7.9) 2,527 (16.4) 1,421 (11.5)
40–49 50,127 (10.3) 11,863 (10.3) 7,949 (8.3) 1,996 (13.0) 1,095 (8.9)
50–64 129,896 (26.7) 33,511 (29.2) 26,320 (27.4) 5,455 (35.5) 4,251 (34.5)
65–74 101,996 (21.0) 26,561 (23.1) 23,756 (24.7) 3,298 (21.5) 3,512 (28.5)
>75 136,599 (28.1) 30,775 (26.8) 29,960 (31.2) 1,997 (13.0) 2,000 (16.3)
Sex
F 218,428 (45.0) 70,105 (61.0) 59,327 (61.7) 9,032 (58.8) 5,682 (46.2)
M 267,356 (55.0) 44,797 (39.0) 36,840 (38.3) 6,338 (41.2) 6,622 (53.8)
Race/ethnicity
Non-Hispanic White 241,534 (49.7) 78,634 (68.4) 67,015 (69.7) 10,267 (66.8) 6,409 (52.1)
Non-Hispanic Black 93,192 (19.2) 14,482 (12.6) 12,736 (13.2) 2,743 (17.8) 3,644 (29.6)
Hispanic 94,476 (19.4) 13,783 (12.0) 9,955 (10.4) 1,348 (8.8) 1,158 (9.4)
Non-Hispanic Asian 13,989 (2.9) 1,446 (1.3) 1,054 (1.1) 122 (0.8) 192 (1.6)
Other or unknown† 42,593 (8.8) 6,557 (5.7) 5,407 (5.6) 890 (5.8) 901 (7.3)
Health insurance
Medicare 236,378 (48.7) 65,874 (57.3) 61,486 (63.9) 8,787 (57.2) 8,264 (67.2)
Medicaid 71,593 (14.7) 15,960 (13.9) 12,591 (13.1) 3,908 (25.4) 2,969 (24.1)
Private 133,735 (27.5) 26,102 (22.7) 17,015 (17.7) 1,817 (11.8) 493 (4.0)
Other† 44,078 (9.1) 6,966 (6.1) 5,075 (5.3) 858 (5.6) 578 (4.7)
Admission month
2020 Mar or earlier 16,773 (3.5) 2,350 (2.0) 1,981 (2.1) 344 (2.2) 481 (3.9)
2020 Apr–Jun 70,536 (14.5) 12,946 (11.3) 11,968 (12.4) 2,578 (16.8) 2,959 (24.0)
2020 Jul–Sep 72,514 (14.9) 15,462 (13.5) 12,696 (13.2) 2,090 (13.6) 1,749 (14.2)
2020 Oct–Dec 149,494 (30.8) 40,166 (35.0) 34,329 (35.7) 4,830 (31.4) 3,651 (29.7)
2021 Jan–Mar 118,438 (24.4) 29,742 (25.9) 24,432 (25.4) 3,686 (24.0) 2,440 (19.8)
2021 Apr–Jun 46,674 (9.6) 11,904 (10.4) 9,076 (9.4) 1,587 (10.3) 863 (7.0)
2021 Jul 11,355 (2.3) 2,332 (2.0) 1,685 (1.8) 255 (1.7) 161 (1.3)
Elixhauser Comorbidity Index‡
4.0 (9.2)
6.2 (10.6)
6.9 (10.8)
5.7 (9.7)
6.4 (9.6)
Hospital characteristics
Urbanicity
Urban 585,009 (88.0) 429,073 (88.3) 99,530 (86.6) 83,505 (86.8) 13,682 (89.0)
Rural 79,947 (12.0) 56,711 (11.7) 15,372 (13.4) 12,662 (13.2) 1,688 (11.0)
Region
East North Central 8,534 (1.8) 3,738 (3.3) 3,193 (3.3) 487 (3.2) 427 (3.5)
East South Central 79,512 (16.4) 15,288 (13.3) 13,917 (14.5) 2,567 (16.7) 2,669 (21.7)
Middle Atlantic 73,667 (15.2) 21,736 (18.9) 18,361 (19.1) 3,052 (19.9) 2,236 (18.2)
Mountain 19,812 (4.1) 6,684 (5.8) 6,544 (6.8) 747 (4.9) 520 (4.2)
New England 133,540 (27.5) 30,544 (26.6) 23,226 (24.2) 3,778 (24.6) 2,965 (24.1)
Pacific 32,915 (6.8) 9,537 (8.3) 7,610 (7.9) 957 (6.2) 608 (4.9)
South Atlantic 64,156 (13.2) 13,504 (11.8) 11,708 (12.2) 1,753 (11.4) 1,290 (10.5)
West North Central 39,377 (8.1) 8,394 (7.3) 6,840 (7.1) 1,180 (7.7) 727 (5.9)
West South Central 34,271 (7.1) 5,477 (4.8) 4,768 (5.0) 849 (5.5) 862 (7.0)

*Values are no. (%) except as indicated. †Missing values, when present, are categorized in the other category. ‡Higher values suggest a higher degree of comorbidity. Expressed as mean (+SD).

Main Article

Page created: June 13, 2022
Page updated: June 18, 2022
Page reviewed: June 18, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external